Cargando…
Gut microbiome alterations in preclinical Alzheimer’s disease
BACKGROUND: Although some human studies have reported gut microbiome changes in individuals with Alzheimer’s disease (AD) dementia or mild cognitive impairment (MCI), gut microbiome alterations in preclinical AD, i.e., cerebral amyloidosis without cognitive impairment, is largely unknown. OBJECTIVE:...
Autores principales: | Jung, Joon Hyung, Kim, Gihyeon, Byun, Min Soo, Lee, Jun Ho, Yi, Dahyun, Park, Hansoo, Lee, Dong Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707757/ https://www.ncbi.nlm.nih.gov/pubmed/36445883 http://dx.doi.org/10.1371/journal.pone.0278276 |
Ejemplares similares
-
Development of a Cognitive Composite for Preclinical Alzheimer’s Disease in Korean Older Adults
por: Kim, Minjae, et al.
Publicado: (2023) -
Early-Life Cognitive Activity Is Related to Reduced Neurodegeneration in Alzheimer Signature Regions in Late Life
por: Ko, Kang, et al.
Publicado: (2018) -
Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies
por: Choi, Hyo Jung, et al.
Publicado: (2017) -
Low Ankle-Brachial Index Relates to Alzheimer-Signature Cerebral Glucose Metabolism in Cognitively Impaired Older Adults
por: Moon, Seok Woo, et al.
Publicado: (2023) -
Body mass index and two-year change of in vivo Alzheimer’s disease pathologies in cognitively normal older adults
por: Lee, Seunghoon, et al.
Publicado: (2023)